$423Million– No. of Holdings #42
| Ticker | $ Bought |
|---|---|
| unitedhealth group inc | 9,858,950 |
| abbott labs | 8,986,910 |
| iqvia hldgs inc | 6,860,820 |
| qiagen nv | 6,501,340 |
| humana inc | 3,329,440 |
| bridgebio pharma inc | 3,286,970 |
| iovance biotherapeutics inc | 3,159,000 |
| denali therapeutics inc | 3,124,030 |
| Ticker | % Inc. |
|---|---|
| elevance health inc formerly | 35.08 |
| ascendis pharma a/s | 30.67 |
| pfizer inc | 26.97 |
| organon & co | 25.32 |
| ptc therapeutics inc | 21.12 |
| biomarin pharmaceutical inc | 20.86 |
| zimmer biomet holdings inc | 17.63 |
| syndax pharmaceuticals inc | 13.47 |
| Ticker | % Reduced |
|---|---|
| gilead sciences inc | -69.82 |
| becton dickinson & co | -37.59 |
| edwards lifesciences corp | -37.34 |
| centene corp del | -37.08 |
| labcorp holdings inc | -29.61 |
| merck & co inc | -28.41 |
| dexcom inc | -26.27 |
| cvs health corp | -23.8 |
| Ticker | $ Sold |
|---|---|
| certara inc | -2,031,280 |
| cg oncology inc | -2,160,660 |
| thermo fisher scientific inc | -12,567,100 |
| hca healthcare inc | -5,034,620 |
| regeneron pharmaceuticals | -5,530,450 |
SECTOR GAMMA AS has about 92.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 92.7 |
| Others | 6 |
| Basic Materials | 1.3 |
SECTOR GAMMA AS has about 74.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 65 |
| MID-CAP | 10.6 |
| MEGA-CAP | 9.7 |
| UNALLOCATED | 6 |
| SMALL-CAP | 5.6 |
| NANO-CAP | 3 |
About 79.5% of the stocks held by SECTOR GAMMA AS either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 69.3 |
| Others | 20.4 |
| RUSSELL 2000 | 10.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
SECTOR GAMMA AS has 42 stocks in it's portfolio. About 54.1% of the portfolio is in top 10 stocks. BDX proved to be the most loss making stock for the portfolio. BMY was the most profitable stock for SECTOR GAMMA AS last quarter.
Last Reported on: 07 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABT | abbott labs | 2.12 | 87,532 | 8,986,910 | new | |||
| AMGN | amgen inc | 3.92 | 47,155 | 16,591,500 | reduced | -22.64 | ||
| ANTX | elevance health inc formerly | 3.04 | 43,962 | 12,869,900 | added | 35.08 | ||
| ARDX | ardelyx inc | 0.73 | 516,131 | 3,091,620 | new | |||
| ARWR | arrowhead pharmaceuticals in | 0.44 | 30,000 | 1,881,000 | new | |||
| ASND | ascendis pharma a/s | 1.15 | 21,305 | 4,873,090 | added | 30.67 | ||
| AVTR | avantor inc | 1.29 | 695,403 | 5,451,960 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc | 0.78 | 44,263 | 3,286,970 | new | |||
| BDX | becton dickinson & co | 3.07 | 82,615 | 12,989,600 | reduced | -37.59 | ||
| BIIB | biogen inc | 3.90 | 90,096 | 16,517,300 | added | 5.41 | ||
| BIO | bio rad labs inc | 1.56 | 23,750 | 6,620,310 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 3.20 | 239,918 | 13,553,000 | added | 20.86 | ||
| BMY | bristol-myers squibb co | 11.86 | 827,901 | 50,212,200 | added | 10.99 | ||
| BRKR | bruker corp | 2.17 | 254,010 | 9,174,840 | reduced | -0.27 | ||
| CAH | cardinal health inc | 2.74 | 54,897 | 11,600,300 | reduced | -11.38 | ||
| CERT | certara inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNC | centene corp del | 1.26 | 162,405 | 5,317,140 | reduced | -37.08 | ||
| COGT | cogent biosciences inc | 0.73 | 80,000 | 3,079,200 | new | |||
| CRNX | crinetics pharmaceuticals in | 0.81 | 94,195 | 3,421,160 | reduced | -18.09 | ||
| CVS | cvs health corp | 2.30 | 135,337 | 9,719,900 | reduced | -23.8 | ||